A 100% increase in S-Cre concentration is a conventional study endpoint in chronic kidney disease (CKD) research, despite a recent study proposing the less stringent criterion of 30%, with the aim to capture more clinical outcomes while retaining prognostic significance3. This evidence concerns the gene C1orf146 and chronic kidney disease.